tc2.ntu.edu.tw
Introduction | 臺灣臨床試驗合作聯盟
http://tc2.ntu.edu.tw/en/lc/intro
Taiwan Lung Cancer Clinical Trial Consortium(TR4). The major tasks of TALCC are (1) to develop a platform sharing the clinical trial related data and information for research collaboration and publications; (2) to promote the international research collaboration, to hold the international symposiums and to provide the members with the information and opportunities for participating in the international clinical trials. Taiwan Lung Cancer Clinical Trial Consortium Secretariat.
tc2.ntu.edu.tw
Introduction | 臺灣臨床試驗合作聯盟
http://tc2.ntu.edu.tw/en/ecc/intro
Taiwan Clinical Trial Consortium for Oncology Phase I Trials(TR5). To provide the means and opportunity to test promising new compounds in Taiwanese patients with advanced solid tumors refractory to standard therapies. To provide high quality and reliable data through ICH-GCP compliant clinical trials for rapid registration and licensing of new compounds in Taiwan. To perform biomarker studies (comprehensive genomic profiling of patients’ tumors). To perform functional imaging. 臺灣臨床試驗合作聯盟 Taiwan Clinical...
tc2.ntu.edu.tw
「4th Japan Taiwan Oncology Phase I Trial Conference (JTOPIC)」研討會 | 臺灣臨床試驗合作聯盟
http://tc2.ntu.edu.tw/zh-hant/news/20150305-218
4th Japan Taiwan Oncology Phase I Trial Conference (JTOPIC) 研討會. 4th Japan Taiwan Oncology Phase I Trial Conference (JTOPIC) 研討會. 4th Japan Taiwan Oncology Phase I Trial Conference (JTOPIC). 2 本研討會之參加學員若全程參與並完成簽到退程序者,將於會後核發 人體試驗相關訓練課程證明書 ,相關學分認證及課程時數將依研討會當日公告為準。 Miss Chou, Miss Hung and Miss Lin Tel: 886 2 2312 3456 ext. 66046. 20150305 4th JTOPIC Agenda(Tentative) web without speaker 20150206.jpg. 臺灣臨床試驗合作聯盟 Taiwan Clinical Trial Consortium.
tc2.ntu.edu.tw
Introduction | 臺灣臨床試驗合作聯盟
http://tc2.ntu.edu.tw/en/tcid/intro
Taiwan Clinical Trial Consortium for Infectious Diseases(TR17). The major missions of our consortium are: 1. establishing a study platform to attract the international, multicenter, clinical trials related to infectious diseases; 2. helping domestic companies to conduct clinical trial to facilitate the marketing of new products related to infectious diseases; 3. supporting the investigator-initiated study programs related infectious diseases. Taiwan Clinical Trial Consortium of Infectious Diseases.
tc2.ntu.edu.tw
Introduction | 臺灣臨床試驗合作聯盟
http://tc2.ntu.edu.tw/en/tlc/intro
Taiwan Clinical Trial Consortium for Liver Disease(TR1). Researches on Hepatitis/HCC: Overview. Chronic viral hepatitis B and C, and related liver diseases (liver cirrhosis and HCC) are still major health problems in Taiwan. After the control of chronic viral hepatitis, nonalcoholic fatty liver diseases (NAFLD) and drug-induced liver injury (DILI) will become the next most common etiologies of liver diseases in Taiwan. A platform for liver disease database management. Room 630, Laboratory Research Buildi...
tc2.ntu.edu.tw
臺灣臨床試驗合作聯盟
http://tc2.ntu.edu.tw/zh-hant
Taiwan Lung Cancer Clinical Trial Consortium. Taiwan Clinical Trial Consortium for Liver Disease. Taiwan Clinical Trial Consortium for Oncology Phase I Trials. Taiwan Clinical Trial Consortium for Helicobacter and GI Disease. Taiwan Clinical Trial Consortium for Gynecologic Oncology. Taiwan Clinical Trial Consortium for Breast Cancer. Taiwan Clinical Trial Consortium for Cardiovascular Diseases. Taiwan Clinical Trial Consortium for Lung Diseases. Taiwan Pediatric Infectious Diseases Alliance.
tc2.ntu.edu.tw
Introduction | 臺灣臨床試驗合作聯盟
http://tc2.ntu.edu.tw/en/tcla/intro
1 Serve as a platform for future cooperative and translational researches for new diagnostic tests, biomarkers, and novel treatment drugs for lipid and atherosclerosis-associated cardiovascular diseases. 2 Establish novel diagnostic tools and treatment drugs for lipid and atherosclerosis-associated cardiovascular disease. Chen CY, Chuang SY, Fang CC, Huang LC, Hsieh IC, Pan WH, Yeh HI, Wu CC, Yin WH, Chen JW. Gender difference in statin intervention on blood lipid control among patients with coronary...
tc2.ntu.edu.tw
Introduction | 臺灣臨床試驗合作聯盟
http://tc2.ntu.edu.tw/en/fabry/intro
Taiwan Clinical Trial Consortium in Fabry Disease is established to solve the foregoing problems. The consortium is comprised of Confirmatory Diagnosis Center, Translational Research Center, Data Management Center, Clinical Research Center and Bio-sample Bank and we strive for excellence in achieving the following objectives:. Set up the Taiwan Clinical Trial Consortium in Fabry Disease as one of the best Fabry disease clinical study groups in the world. Taiwan Lung Cancer Clinical Trial Consortium(TR4).
tc2.ntu.edu.tw
103年度第二次臨床試驗計畫書通過清單 | 臺灣臨床試驗合作聯盟
http://tc2.ntu.edu.tw/zh-hant/news/20140611-187
E-mail gjshieh@ntu.edu.tw. 臺灣臨床試驗合作聯盟 Taiwan Clinical Trial Consortium.
tc2.ntu.edu.tw
Introduction | 臺灣臨床試驗合作聯盟
http://tc2.ntu.edu.tw/en/tgog/intro
Gynecological cancers, including cervical cancer, uterine cancer and ovarian/fallopian tube/peritoneal cancer are devastating diseases that affect more than 4300 women each year in Taiwan. Although currentmedical technology prolongs cancer patient survival, approximately 1300 women still died from these diseases annually. To establish the platform of TGOG by integrating clinical and basic researchers of of gynecologic oncology all over Taiwan and carry out national and international multi-center clinical...